Fairvalue-Calculator Fairvalue-Calculator
EN DE

Actinogen Medical Limited (ACW) Fair Value & Analysis

Healthcare · AU · Market cap A$129M

PriceA$0.0330
Fair ValueA$0.0200
Upside-39.4%
Quality95/100
Evidence: Low Range A$0.0200 – A$0.0300

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Actinogen Medical Limited (ACW) currently trades at A$0.0330, while our model-based Fair Value estimate is A$0.0200 — implying the stock looks roughly 39.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Actinogen Medical Limited (ACW) undervalued?
As of Jun 24, 2026, our model estimates a fair value of A$0.0200 versus a price of A$0.0330 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ACW?
Our 21-model fair value for Actinogen Medical Limited is A$0.0200 (as of Jun 24, 2026), built from audited fundamentals. The current price is A$0.0330.
What is the quality score of ACW?
Actinogen Medical Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.